异常的异性染色素使慢性淋巴细胞白血病中的免疫反应基因沉默
Olivia M Depies1, Qianqian Guo2, Yuan Gao3
1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Blood neoplasia
|June 2, 2025
概括
通过异性染色体标记 (H3K9me3,H3K27me3) 的表观遗传沉默会损害慢性淋巴细胞白血病 (CLL) 和其前体 (MBL) 的免疫基因. 这种沉默在疾病进展和治疗过程中持续存在.
科学领域:
- 血液学 血液学 血液学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 在慢性淋巴细胞白血病 (CLL) 中观察到表观遗传变化,但它们的功能意义尚未完全理解.
- 了解这些表观遗传变化对于破译CLL病变和演变至关重要.
研究的目的:
- 在CLL患者样本中描述全基因组基因组基因组修饰景观.
- 调查表观遗传沉默在CLL发展及其前体单克隆B细胞淋巴细胞病 (MBL) 中的作用.
- 探索这些表观遗传标记在疾病进展和治疗期间的稳定性.
主要方法:
- 在CLL和正常B细胞中对基因组基因组修饰的全基因组分析.
- 在增强剂中使用ChIP-seq来识别异性染色素标记 (H3K9me3,H3K27me3).
- 针对EBF1基因位置的案例研究.
- 在不同疾病阶段和在ibrutinib治疗期间分析患者样本.
主要成果:
- CLL B 细胞表现出与下调免疫反应基因相关的特定增强剂损失.
- 丢失的增强剂表现出增加的异染色素标记 (H3K9me3,H3K27me3).
- 在EBF1位点获得的H3K9me3有助于增强沉默和基因抑制.
- 在MBL细胞中存在异常的染色体签名,表明早期的表观遗传沉默.
- 沉默增强剂在ibrutinib治疗期间保持稳定,与CLL增强剂不同.
结论:
- 由异色染色体介导的表观遗传沉默是CLL进化和治疗中的持续机制.
- 这种沉默会影响免疫反应基因,并可能增加MBL和CLL的感染风险.
- 了解这些表观遗传变化为CLL提供了潜在的治疗见解.
更多相关视频
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.5K
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
7.7K
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Inheritance of Chromatin Structures
6.6K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.6K
Heterochromatin
14.6K
The extent of chromatin compaction can be studied by staining chromatin using specific DNA binding dyes. Under the microscope, the dense-compacted regions that take up more dye are called heterochromatin. Heterochromatin is further classified into two forms – constitutive heterochromatin and facultative heterochromatin.
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...
14.6K
Cells of the Adaptive Immune Response
4.8K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.8K
Disorders of Leukocytes
1.2K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.2K
B Cell Activation and Differentiation
6.9K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
6.9K
